Harold R. Zimmer - Net Worth and Insider Trading
Harold R. Zimmer Net Worth
The estimated net worth of Harold R. Zimmer is at least $431,430 dollars as of 2024-09-24. Harold R. Zimmer is the Director of Knight Therapeutics Inc and owns about 73,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $431,430. Details can be seen in Harold R. Zimmer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harold R. Zimmer has not made any transactions after 2019-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harold R. Zimmer
Harold R. Zimmer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harold R. Zimmer owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Harold R. Zimmer’s form 4 insider trades.
Insider Ownership Summary of Harold R. Zimmer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-07 | Director |
Harold R. Zimmer Latest Holdings Summary
Harold R. Zimmer currently owns a total of 1 stock. Harold R. Zimmer owns 73,000 shares of Knight Therapeutics Inc (TSX:GUD) as of August 7, 2019, with a value of $431,430.
Latest Holdings of Harold R. Zimmer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-07 | 73,000 | 5.91 | 431,430 |
Holding Weightings of Harold R. Zimmer
Harold R. Zimmer Form 4 Trading Tracker
According to the SEC Form 4 filings, Harold R. Zimmer has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 1,000 shares on August 7, 2019, which cost Harold R. Zimmer around $7,380.
Insider Trading History of Harold R. Zimmer
- 1
Harold R. Zimmer Trading Performance
GuruFocus tracks the stock performance after each of Harold R. Zimmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harold R. Zimmer is 13.19%. GuruFocus also compares Harold R. Zimmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harold R. Zimmer within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harold R. Zimmer's insider trading performs compared to the benchmark.
Performance of Harold R. Zimmer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.91 | | | | | |
| Relative Return to S&P 500(%) | 6.63 | | | | | |
Harold R. Zimmer Ownership Network
Harold R. Zimmer Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Harold R. Zimmer is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Harold R. Zimmer made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Harold R. Zimmer Mailing Address
Above is the net worth, insider trading, and ownership report for Harold R. Zimmer. Currently GuruFocus does not have mailing address information for Harold R. Zimmer.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
